UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes

PloS one, 2011-10, Vol.6 (10), p.e25792-e25792

2011

Volltextzugriff (PDF)

Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats

PloS one, 2010-05, Vol.5 (5), p.e10507-e10507

2010

Volltextzugriff (PDF)

Toward defining the autoimmune microbiome for type 1 diabetes

The ISME Journal, 2011-01, Vol.5 (1), p.82-91

2011

Volltextzugriff (PDF)

Central Role for Interleukin-2 in Type 1 Diabetes

Diabetes (New York, N.Y.), 2012-01, Vol.61 (1), p.14-22

2012

Volltextzugriff (PDF)

Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis

Diabetes (New York, N.Y.), 2020-03, Vol.69 (3), p.413-423

2020

Volltextzugriff (PDF)

Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes

Diabetologia, 2021-08, Vol.64 (8), p.1822-1833

2021

Volltextzugriff (PDF)

Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrPC, in type 1 diabetes

Diabetologia, 2021-10, Vol.64 (10), p.2279-2291

2021

Volltextzugriff (PDF)

Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens

Diabetes (New York, N.Y.), 2015-01, Vol.64 (1), p.158-171

2015

Volltextzugriff (PDF)

An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes

Frontiers in immunology, 2024-03, Vol.15, p.1367514-1367514

2024

Volltextzugriff (PDF)

Impaired islet function and normal exocrine enzyme secretion occur with low inter-regional variation in type 1 diabetes

Cell reports (Cambridge), 2024-06, Vol.43 (6), p.114346-114346, Article 114346

2024

Volltextzugriff (PDF)

Functional Defects and the Influence of Age on the Frequency of CD4+CD25+ T-Cells in Type 1 Diabetes

Diabetes (New York, N.Y.), 2005-05, Vol.54 (5), p.1407-1414

2005

Volltextzugriff (PDF)

Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development

Frontiers in endocrinology (Lausanne), 2023, Vol.14, p.1275316-1275316

2023

Volltextzugriff (PDF)

Minimal change disease: a dysregulation of the podocyte CD80–CTLA-4 axis?

Pediatric nephrology (Berlin, West), 2014-12, Vol.29 (12), p.2333-2340

2014

Volltextzugriff (PDF)

Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults

Frontiers in immunology, 2017-06, Vol.8, p.655-655

2017

Volltextzugriff (PDF)

Serological autoantibody profiling of type 1 diabetes by protein arrays

Journal of proteomics, 2013-12, Vol.94, p.486-496

2013

Volltextzugriff (PDF)

Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model

Journal of translational medicine, 2011-02, Vol.9 (1), p.21-21, Article 21

2011

Volltextzugriff (PDF)

Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation

PloS one, 2009-11, Vol.4 (11), p.e7980-e7980

2009

Volltextzugriff (PDF)

A streamlined tandem tip-based workflow for sensitive nanoscale phosphoproteomics

Communications biology, 2023-01, Vol.6 (1), p.70-12, Article 70

2023

Volltextzugriff (PDF)

A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry

Cell metabolism, 2019-03, Vol.29 (3), p.755-768.e5

2019

Volltextzugriff (PDF)

Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes

Diabetes care, 2009-11, Vol.32 (11), p.2041-2046

2009

Volltextzugriff (PDF)

Human immune phenotyping reveals accelerated aging in type 1 diabetes

JCI insight, 2023-09, Vol.8 (17)

2023

Volltextzugriff (PDF)

Immune Depletion With Cellular Mobilization Imparts Immunoregulation and Reverses Autoimmune Diabetes in Nonobese Diabetic Mice

Diabetes (New York, N.Y.), 2009-10, Vol.58 (10), p.2277-2284

2009

Volltextzugriff (PDF)

Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes

Pediatric nephrology (Berlin, West), 2013-09, Vol.28 (9), p.1803-1812

2013

Volltextzugriff (PDF)

The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice

PloS one, 2012-05, Vol.7 (5), p.e36079-e36079

2012

Volltextzugriff (PDF)

Tissue registration and exploration user interfaces in support of a human reference atlas

Communications biology, 2022-12, Vol.5 (1), p.1369-1369, Article 1369

2022

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(121)

Sprache

Englisch
(121)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Life Sciences & Biomedicine
(81)
Humans
(61)
Animals
(50)
Diabetes
(48)
Female
(47)
Mice
(36)
Endocrinology & Metabolism
(35)
Type 1 Diabetes
(34)
Male
(33)
Diabetes Mellitus, Type 1 - Immunology
(26)
Diabetes Mellitus
(25)
Immunology
(25)
Mice, Inbred Nod
(24)
Biological And Medical Sciences
(21)
Cytokines
(19)
Medical Sciences
(19)
Science & Technology - Other Topics
(19)
Child
(18)
Diabetes Mellitus, Type 1 - Metabolism
(18)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes

Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats

Toward defining the autoimmune microbiome for type 1 diabetes

Central Role for Interleukin-2 in Type 1 Diabetes

Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis

Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes

Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrPC, in type 1 diabetes

Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens

An antigen-specific immunotherapeutic, AKS-107, deletes insulin-specific B cells and prevents murine autoimmune diabetes

Impaired islet function and normal exocrine enzyme secretion occur with low inter-regional variation in type 1 diabetes

Functional Defects and the Influence of Age on the Frequency of CD4+CD25+ T-Cells in Type 1 Diabetes

Footprint of pancreas infiltrating and circulating immune cells throughout type 1 diabetes development

Minimal change disease: a dysregulation of the podocyte CD80–CTLA-4 axis?

Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults

Serological autoantibody profiling of type 1 diabetes by protein arrays

Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model

Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation

A streamlined tandem tip-based workflow for sensitive nanoscale phosphoproteomics

A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry

Autologous Umbilical Cord Blood Transfusion in Very Young Children With Type 1 Diabetes

Human immune phenotyping reveals accelerated aging in type 1 diabetes

Immune Depletion With Cellular Mobilization Imparts Immunoregulation and Reverses Autoimmune Diabetes in Nonobese Diabetic Mice

Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes

The tyrphostin agent AG490 prevents and reverses type 1 diabetes in NOD mice

Tissue registration and exploration user interfaces in support of a human reference atlas

Suchergebnisse filtern